Clinical Trials in Xianyang, Shaanxi
20 recruiting
Showing 1–19 of 19 trials
Recruiting
Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pediatric Migraine
Pfizer2,100 enrolled109 locationsNCT04649242
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Secondary-progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals1,275 enrolled164 locationsNCT07225504
Recruiting
Phase 3
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
Generalized Myasthenia Gravis
Novartis Pharmaceuticals146 enrolled112 locationsNCT06517758
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Pfizer723 enrolled122 locationsNCT06641466
Recruiting
Phase 4
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
Acute Severe Ulcerative Colitis
Xijing Hospital of Digestive Diseases226 enrolled4 locationsNCT07550673
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
bone metastasisPSMA PETProstate Cancer (Diagnosis)+4 more
Xijing Hospital1,000 enrolled9 locationsNCT07553754
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Treatment ResponseHigh-risk Prostate CancerPSMA PET+1 more
Xijing Hospital110 enrolled9 locationsNCT07553780
Recruiting
Phase 3
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Intracerebral Hemorrhage
Beijing Tiantan Hospital1,192 enrolled41 locationsNCT07338175
Recruiting
Phase 4
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
Acute Severe Ulcerative Colitis
Yongquan Shi46 enrolled4 locationsNCT07546097
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Molecular ImagingSuspected Prostate CancerTreatment-naive Prostate Cancer
Xijing Hospital1,000 enrolled9 locationsNCT07531329
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
AIS
Biocells (Beijing) Biotech Co.,Ltd1,112 enrolled9 locationsNCT07520565
Recruiting
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Clinically Significant Prostate Cancer
Xijing Hospital1,700 enrolled10 locationsNCT07492927
Recruiting
Phase 3
Optimizing Early Nutrition Support in Severe Stroke-2
severe strokeAcute StrokeDysphagia
Wen Jiang-3546 enrolled30 locationsNCT05998902
Recruiting
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital1,000 enrolled9 locationsNCT07474142
Recruiting
Not Applicable
68Ga-PSMA PET in the Renal Cell Carcinoma
MetastasesRenal CancerPSMA PET
Xijing Hospital300 enrolled9 locationsNCT04987086
Recruiting
Phase 2
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.300 enrolled23 locationsNCT07279493
Recruiting
Phase 3
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.246 enrolled60 locationsNCT07107256
Recruiting
Phase 4
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
Mild stroke
Second Affiliated Hospital of Soochow University580 enrolled18 locationsNCT07095790
Recruiting
Not Applicable
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Retinopathy of Prematurity (ROP)
Wang Yusheng146 enrolled3 locationsNCT06717412